United States · 
Who invested in Ratio Therapeutics?
Ratio Therapeutics's investors include Eli Lilly and Catalio Capital Management.
United States · Series C startup
Who invested in Ratio Therapeutics
Funding summaryUpdated 26 Oct 2026
$70Mraised across 1 round since 2026, from 1 source
- Latest round
- Series C, $70MJul 2026
- Investors
- 2
The rounds
- Jul 2026
Everyone who backed them
Missing a round, or an investor who was in one? Tell us.
Quick answers about Ratio Therapeutics
How much has Ratio Therapeutics raised?
Ratio Therapeutics has raised $70M across 1 round since 2026.
When did Ratio Therapeutics last raise?
Ratio Therapeutics's most recent round was a Series C of $70M in Jul 2026.
What was Ratio Therapeutics's biggest round?
Its most recent round, $70M in Jul 2026, is also its largest on record.
Who backed Ratio Therapeutics first?
Ratio Therapeutics's first round on record, in Jul 2026, was backed by Eli Lilly and Catalio Capital Management.
What stage is Ratio Therapeutics at?
Ratio Therapeutics's latest named round is a Series C, in Jul 2026.
Where is Ratio Therapeutics based?
Ratio Therapeutics is based in the United States.
Companies like Ratio Therapeutics
In the same sector, and raised in the last eighteen months.
Find investors like these
Search every investor by what they have actually funded, then narrow to your stage and market. Free.